Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Science News New Immunotherapy Drugs Target Two Evasive Cancer Driving Proteins Science Magazine is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Trial for immunotherapy drug shows promise for aggressive breast cancer
University of Hawaiʻi Cancer Center researchers have conducted a phase II clinical trial investigating the potential of pembrolizumab maintenance therapy, a type of immunotherapy, in aggressive forms ... Read More
Super-Quiz for Science
A version of this article appears in the February 2, 1952 issue of Science News. Love our Health & Medicine stories? Our coverage would not be possible without the generous support of subscribers ... Read More
Lung Cancer News
Genetic Signature May Predict Response to Immunotherapy ... A novel drug target has been newly identified in the fight against drug resistance in cancer ... Small Cell Lung Cancer: New Approach ... Read More
Structures of new cancer drug candidates revealed
The company plans to partner with Pfizer on a Phase 2 study. The cancer immunotherapy ... therapies that target RTK proteins. However, cancer cells can resist these drugs using a mechanism called ... Read More
Prostate Cancer News
Promising New Options for Treating Aggressive Prostate Cancer Oct. 18, 2023 — Investigators have identified two ... drug, a multi-institution, Phase 3 clinical trial has ... New Approach to ... Read More
New insights could unlock immunotherapy for rare, deadly eye cancer
New research from the University of Pittsburgh explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy, which involves growing a patient’s T cells ... Read More
New trial shows immunotherapy post-surgery improves overall survival for kidney cancer
For the first time in fifty years, results from a Phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer. Read More
The Next Generation of Cancer Drugs Will Be Made in Space
Immunotherapy is one of the most promising new ways to fight cancer ... that microgravity can give to life science research, drug development, cancer research—and more that we just don't ... Read More
Smart News Science
millions of Americans looked up and were spellbound by the spectacular phenomenon Two specific broods will appear together for the first time since 1803 The two babies are part of an endangered ... Read More
Science
April 17, 2024 • 500 million years ago, the world was a very different place. During this period of time, known as the Cambrian period, basically all life was in the water. The ocean was ... Read More
Scientists discover new 'wonder' drug for aggressive cancer
Half were also given injections of new drug, ADI-PEG20 (pegargiminase) while the other half received a placebo – also known as a dummy drug – for two ... science engagement manager at Cancer ... Read More
The New Science of Death
We preselected all newsletters you had before unsubscribing. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus